Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Volumn 20, Issue 9, 2014, Pages 879-885

  Chung, S D ^a,b   Tsai, M C ^c   Lin, H C ^b   Kang, J H ^b,d  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c General Cathay Hospital   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Pneumonia; Respiratory failure; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

ACUTE RESPIRATORY FAILURE; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; DEATH; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PNEUMONIA; PRIORITY JOURNAL; TAIWAN; TREATMENT OUTCOME; CASE CONTROL STUDY; INTENSIVE CARE; RESPIRATORY INSUFFICIENCY; STATISTICS AND NUMERICAL DATA; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PNEUMONIA; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SURVIVAL ANALYSIS; TAIWAN; TREATMENT OUTCOME;

EID: 84908022728     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12544     Document Type: Article

References (28)

1. Hou W, Lv J, Perkovic V et al. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. Eur Heart J 2013; 34: 1807-1817.
2. Ray K. Statin diabetogenicity: guidance for clinicians. Cardiovasc Diabetol 2013; 12: S3.
3. Gutierrez J, Ramirez G, Rundek T, Sacco RL. Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med 2012; 172: 909-919.
4. Ni Chroinin D, Asplund K, Asberg S et al. Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke 2013; 44: 448-456.
5. Novack V, Eisinger M, Frenkel A et al. The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med 2009; 35: 1255-1260.
6. Chaudhry MZ, Wang JH, Blankson S, Redmond HP. Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance. Surg Infect 2008; 9: 183-194.
7. Ky B, Rader DJ. The effects of statin therapy on plasma markers of inflammation in patients without vascular disease. Clin Cardiol 2005; 28: 67-70.
8. Ito MK, Talbert RL, Tsimikas S. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction. Pharmacotherapy 2006; 26: 85S-97S.
9. Sadowitz B, Maier KG, Gahtan V. Basic science review: Statin therapy - Part I: The pleiotropic effects of statins in cardiovascular disease. Vasc Endovascular Surg 2010; 44: 241-251.
10. Chalmers JD, Short PM, Mandal P, Akram AR, Hill AT. Statins in community acquired pneumonia: evidence from experimental and clinical studies. Respir Med 2010; 104: 1081-1091.
11. Janda S, Young A, Fitzgerald JM, Etminan M, Swiston J. The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis. J Crit Care 2010; 25: 656.
12. Chopra V, Rogers MA, Buist M et al. Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis. Am J Med 2012; 125: 1111-1123.
13. Yang KC, Chien JY, Tseng WK, Hsueh PR, Yu CJ, Wu CC. Statins do not improve short-term survival in an oriental population with sepsis. Am J Emerg Med 2007; 25: 494-501.
14. Kang JH, Chen YH, Lin HC. Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis 2010; 69: 1165-1168.
15. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011; 20: 236-242.
16. Chen YC, Yeh HY, Wu JC, Haschler I, Chen TJ, Wetter T. Taiwan's National Health Insurance Research Database: administrative health care database as study object in bibliometrics. Scientometrics 2011; 86: 365-380.
17. Chen YH, Lin HC, Lin HC. Poor clinical outcomes among pneumonia patients with schizophrenia. Schizophr Bull 2011; 37: 1088-1094.
18. Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 2007; 26: 734-753.
19. Wang MT, Lo YW, Tsai CL et al. Statin use and risk of COPD exacerbation requiring hospitalization. Am J Med 2013; 126: 598-606.
20. Yende S, Milbrandt EB, Kellum JA et al. Understanding the potential role of statins in pneumonia and sepsis. Crit Care Med 2011; 39: 1871-1878.
21. Leung S, Pokharel R, Gong MN. Statins and outcomes in patients with bloodstream infection: a propensity-matched analysis. Crit Care Med 2012; 40: 1064-1071.
22. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respir Res 2005; 6: 82.
23. Nielsen AG, Nielsen RB, Riis AH, Johnsen SP, Sorensen HT, Thomsen RW. The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study. Crit Care 2012; 16: R122.
24. Dublin S, Jackson ML, Nelson JC, Weiss NS, Larson EB, Jackson LA. Statin use and risk of community acquired pneumonia in older people: population based case-control study. BMJ 2009; 338: b2137.
25. Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest 2007; 131: 1006-1012.
26. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006; 333: 999.
27. Makris D, Manoulakas E, Komnos A et al. Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: open-label, randomized study. Crit Care Med 2011; 39: 2440-2446.
28. Papazian L, Roch A, Charles PE et al. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. JAMA 2013; 310: 1692-1700.